Cox, Joseph
Linthwaite, Blake
Engler, Kim
Lessard, David
Lebouché, Bertrand
Kronfli, Nadine
Funding for this research was provided by:
ViiV Healthcare
Article History
Received: 4 July 2019
Accepted: 27 January 2020
First Online: 21 February 2020
Ethics approval and consent to participate
: Approval was obtained by the Ethics Committee at the McGill University Health Centre (2018-4369), who will review and monitor this study. All efforts will be made to ensure the confidentiality of participants, including the use of randomised study codes, encryption of electronic documents on password-protected hospital servers, secure storage of printed materials, and timely destruction of study documents. In lieu of individual informed consent of patients, authorization to access patient charts will be obtained from the Director of Professional Services (DPS) of the MUHC Glen Site – Adult Sector.This is a nurse-led study and all nurses have already agreed to participate. They are not being consented by a boss or direct supervisor, but instead by the research coordinator for this study. Participation is voluntary and nurses can withdraw at any time or decline to participate without affecting their employment.Given limited to no risk of harms to participants, no data monitoring committee will be involved in data oversight.
: The signed informed consent form will be obtained by the investigator prior to inclusion in the study and scientific use of acquired data.
: JC has received consulting fees from ViiV Healthcare, Merck, and Gilead; research funding from ViiV Healthcare, Merck, and Gilead; and payment for lectures from Gilead. BL<sup>2</sup> has received consulting fees from ViiV Healthcare and Gilead; research funding from Merck, Gilead, and Abbvie; and payment for lectures from Merck and Gilead. NK has received consulting fees from ViiV Healthcare, Merck, and Gilead; research funding from ViiV Healthcare and Gilead; and payment for lectures from Gilead. All other authors declare that they have no competing interests.